StonvexLoading…
StonvexStonvexStonvexCore line items from IBO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $7.00K | $32.00K | $25.00K | $7.00K |
Operating Income | $-2.29M | $-4.28M | $-3.11M | $-2.17M |
Net Income | $-2.29M | $-11.84M | $-17.08M | $-15.61M |
EPS (Diluted) | $-0.02 | $-0.38 | $-1.41 | $-1.29 |
Total Assets | $17.09M | $17.41M | $18.21M | $19.06M |
Total Liabilities | $2.38M | $1.85M | $27.06M | $26.44M |
Cash & Equivalents | $20.00K | $3.00K | $12.00K | $624.00K |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 107.82M | 104.62M | 12.19M | 12.19M |